Marshall Wace
RCKT icon

Marshall Wace’s Rocket Pharmaceuticals RCKT Stock Holding History

Marshall Wace’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8M Buy
4,029,262
+990,547
+33% +$3.29M 0.01% 899
2026
Q1 		$10.9M Buy
3,038,715
+3,012,368
+11,433% +$12M 0.01% 936
2025
Q4 		$92.5K Buy
+26,347
New +$90.2K ﹤0.01% 2720
2025
Q2 		– Sell
-438,617
Closed -$2.93M – 3078
2025
Q1 		$2.93M Sell
438,617
-18,145
-4% -$179K ﹤0.01% 1301
2024
Q4 		$5.74M Buy
456,762
+446,662
+4,422% +$6.72M 0.01% 1000
2024
Q3 		$187K Sell
10,100
-9,483
-48% -$194K ﹤0.01% 2304
2024
Q2 		$422K Buy
+19,583
New +$450K ﹤0.01% 2023
2023
Q1 		– Sell
-13,500
Closed -$264K – 3032
2022
Q4 		$264K Sell
13,500
-88,356
-87% -$1.63M ﹤0.01% 2604
2022
Q3 		$1.63M Buy
101,856
+88,056
+638% +$1.37M ﹤0.01% 2148
2022
Q2 		$190K Buy
+13,800
New +$165K ﹤0.01% 3179
2022
Q1 		– Sell
-95,569
Closed -$2.08M – 3905
2021
Q4 		$2.08M Buy
+95,569
New +$2.61M ﹤0.01% 2012
2021
Q1 		– Sell
-35,390
Closed -$1.94M – 2794
2020
Q4 		$1.94M Buy
+35,390
New +$1.29M 0.01% 965
2020
Q1 		– Sell
-3,877
Closed -$88K – 1989
2019
Q4 		$88K Buy
3,877
+2,573
+197% +$43K ﹤0.01% 1473
2019
Q3 		$15K Sell
1,304
-130,444
-99% -$1.62M ﹤0.01% 1609
2019
Q2 		$1.98M Sell
131,748
-14,244
-10% -$249K 0.02% 770
2019
Q1 		$2.56M Buy
+145,992
New +$2.3M 0.02% 665

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marshall Wace's RCKT Position: Q2 2026 in Review

Marshall Wace increased its Rocket Pharmaceuticals (RCKT) stake by 33% in Q2 2026, buying an estimated $3.29M and bringing the position to 4,029,262 shares worth $13.8M. The position accounts for 0.01% of the portfolio, ranked #899.

Marshall Wace first reported a position in RCKT in Q1 2019 and has held it in 16 quarters since. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Marshall Wace held 4,029,262 shares of Rocket Pharmaceuticals worth $13.8M as of Q2 2026.
  • Marshall Wace bought 990,547 Rocket Pharmaceuticals shares in Q2 2026, an estimated $3.29M.
  • Rocket Pharmaceuticals made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #899 holding.
  • Marshall Wace first reported a position in Rocket Pharmaceuticals in Q1 2019 and has held it in 16 quarters since.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.